Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Plos One|May 3, 2014
Are the 10 meter and 6 minute walk tests redundant in patients with spinal cord injury?Gail F Forrest, Karen Hutchinson, Douglas J Lorenz, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2010
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicityMichele Basso, Anna Modoni, Daniele Spada, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|July 27, 2019
Operator learning curve for transradial liver cancer embolization: implications for the initiation of a transradial access programRoberto Iezzi, Alessandro Posa, Biagio Merlino, et al.
Future Oncology (London, England)|March 13, 2018
Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?Sabrina Rossi, Vincenzo Di Noia, Laura Tonetti, et al.
Current Treatment Options in Oncology|February 22, 2019
Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"Vincenzo Di Noia, Emanuele Vita, Miriam Ferrara, et al.
Journal of Neuropathology and Experimental Neurology|September 17, 2021
Histological Findings After Aortic Cross-Clamping in Preclinical Animal ModelsHamdy Awad, Alexander Efanov, Jayanth Rajan, et al.
Cardiovascular and Interventional Radiology|March 25, 2015
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center StudyRoberto Iezzi, Valentina Angela Marsico, Alessandra Guerra, et al.
Archives of Physical Medicine and Rehabilitation|August 28, 2012
Ambulation and balance outcomes measure different aspects of recovery in individuals with chronic, incomplete spinal cord injuryGail F Forrest, Douglas J Lorenz, Karen Hutchinson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 9, 2013
Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in miceChristopher N Hansen, Lesley C Fisher, Rochelle J Deibert, et al.
Personalized Medicine|June 22, 2018
The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'Michele Basso, Vincenzo Dadduzio, Sabrina Rossi, et al.
Pageof 13